Vitamin D and Chronic Disorders: A Review of Metabolic and Cardiovascular Diseases
Pharmaceuticals · 29.09.2025 · 18 (10) · 1467
DOI: 10.3390/ph18101467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 29.09.2025. Verfasst von Ewelina Młynarska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrocardiology, Medical University of Lodz, 90-419 Lodz, Poland. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vitamin D, long recognized for its essential role in calcium–phosphate balance and bone health, has increasingly been identified as a pleiotropic regulator of metabolic, cardiovascular, and renal function. Deficiency of vitamin D is widespread worldwide and has been linked to a higher risk of insulin resistance, type 2 diabetes, atherosclerosis, hypertension, and chronic kidney disease. Meta-analyses suggest that each 10 nmol/L (≈4 ng/mL) increase in serum 25-hydroxyvitamin D [25(OH)D] is associated with about a 4% lower risk of type 2 diabetes, whereas other analyses indicate an approximately 10% reduction in cardiovascular event risk per 10 ng/mL (≈25 nmol/L) increment in circulating 25(OH)D concentration. Clinical and epidemiological studies suggest that optimal 25(OH)D concentrations may protect against cardiometabolic and renal complications, though supplementation trials show heterogeneous outcomes depending on baseline vitamin D status, genetic background, and dosage. By synthesizing current knowledge, this work highlights vitamin D status as a potentially modifiable determinant of global disease burden and a target for preventive and therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrocardiology, Medical University of Lodz, 90-419 Lodz, Poland.
- Department of Nephrology, Hypertension and Internal Medicine, Medical University of Lodz, 90-549 Lodz, Poland.
ORCID-Profile: Ewelina Młynarska, Wiktoria Lisińska, Katarzyna Hossa, Paulina Jakubowska
Zitieren
APA
Młynarska, E., Lisińska, W., Hossa, K., Krupińska, N., Jakubowska, P., Rysz, J., & Franczyk, B. (2025). Vitamin D and Chronic Disorders: A Review of Metabolic and Cardiovascular Diseases. Pharmaceuticals, 18(10), 1467. https://doi.org/10.3390/ph18101467
Vancouver
Młynarska E, Lisińska W, Hossa K, Krupińska N, Jakubowska P, Rysz J, et al. Vitamin D and Chronic Disorders: A Review of Metabolic and Cardiovascular Diseases. Pharmaceuticals. 2025;18(10):1467. doi:10.3390/ph18101467
BibTeX
@article{Mynarska2025,
author = {Młynarska, Ewelina and Lisińska, Wiktoria and Hossa, Katarzyna and Krupińska, Natalia and Jakubowska, Paulina and Rysz, Jacek and Franczyk, Beata},
title = {Vitamin D and Chronic Disorders: A Review of Metabolic and Cardiovascular Diseases},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {10},
pages = {1467},
doi = {10.3390/ph18101467}
}
EUVIMED